A. Andrew Hindman

Affiliations

  • Svp, Chief Financial Officer at Theravance Biopharma Inc. (TBPH), 2022-11-22
  • Chief Business Officer at Acorda Therapeutics Inc (ACOR), 2019-03-12
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
TBPH $11.02 65,000 $716,241.50 409,771 2022-11-18 Filing
ACOR $20.56 753 $15,478.37 5,171 2018-12-03 Filing
ACOR $24.26 42,615 $1,034,006.10 4,503 2018-05-25 Filing
ACOR $20.54 817 $16,784.12 45,306 2017-12-01 Filing
ACOR $15.75 7,704 $121,318.74 46,123 2017-05-15 Filing